Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 3/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.37 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.37 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CD69 | Q07108 | 1/20 | 0.35 |
| ▸ | GJB2 | P29033 | 1/20 | 0.34 |
| ▸ | FGF1 | P05230 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21391533 | 0.89 | LGALS3 (0.47) | LGALS8LGALS3LGALS4AMY1AKDM4E | |
| SCHEMBL22906103 | 0.85 | LGALS8 (0.44) | LGALS8KDM4EPOLBFGF1 | |
| SCHEMBL22906178 | 0.82 | PYGB (0.40) | — | |
| SCHEMBL22906121 | 0.82 | PYGB (0.40) | — | |
| SCHEMBL21391520 | 0.82 | PYGB (0.40) | — | |
| SCHEMBL21391551 | 0.82 | PYGB (0.40) | — | |
| SCHEMBL21391503 | 0.80 | AMY1A (0.35) | LGALS8LGALS3LGALS4AMY1AKDM4E | |
| SCHEMBL12198736 | 0.75 | LGALS8 (0.53) | LGALS8LGALS3LGALS4KDM4EPOLB | |
| SCHEMBL10301424 | 0.75 | LGALS8 (0.53) | LGALS8LGALS3LGALS4KDM4EPOLB | |
| SCHEMBL22906135 | 0.73 | LGALS8 (0.48) | LGALS8LGALS3LGALS4KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210017211-A1 | OLIGOSACCHARIDE C-GLYCOSIDE DERIVATIVES | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210017211-A1 | OLIGOSACCHARIDE C-GLYCOSIDE DERIVATIVES | OSTC, FUT6, FUT5 | LGALS8 253/4885LGALS3 188/4885LGALS4 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.